We provide you with 20 years of free, institutional-grade data for PLXP stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PLXP. Explore the full financial landscape of PLXP stock.
| Reported Date | CIK | Ticker | Type |
|---|
PLx Pharma Inc(NASDAQ:PLXP) 
PLx Pharma Inc., a specialty pharmaceutical company, focuses on developing the PLxGuard drug delivery system to provide various products in the United States. The company's lead product candidates are Vazalore 325 mg and Vazalore 81 mg, which are formulations of aspirin that use the PLxGuard deliver...
Website: http://plxpharma.com
Full Time Employees: 8 (May 2021)
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report about PLXP stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.